Science & Technology Review May 2019
Lawrence Livermore’s “brain-on-a-chip” is designed to predict the effects of potentially harmful chemicals, viruses, and drugs on humans without relying on animal or human test subjects. In conjunction with an artificial blood–brain barrier, the device simulates the central nervous system by recording activity from brain cells grown onto a small platform embedded with microelectrode arrays. The brain-on-a-chip holds significant promise for national security and broader applications. For example, the device could be used to determine how soldiers are affected by exposure to chemical and biological weapons and the effectiveness of potential countermeasures and prophylactic pretreatments. The technology could also help predict the effects on the brain from promising drugs designed to treat neurological disorders. The brain-on-a-chip is the latest iteration of the Laboratory’s iCHIP (in vitro chip-based human investigational platform) project—a broad initiative at Livermore to advance human health with a focus on understanding, diagnosing, and potentially treating human neural problems and diseases.